Literature DB >> 10381126

Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma.

T C Chen1, L L Hsieh, K F Ng, L B Jeng, M F Chen.   

Abstract

APC gene mutations have been demonstrated not only in colorectal carcinoma but also in a variety of human cancers. To define the possible role of mutations of the APC gene in hepatocarcinogenesis, we examined 46 pairs of hepatocellular carcinomas and corresponding non-tumorous liver tissue by polymerase chain reaction and single strand conformation polymorphism. All 46 hepatocellular carcinomas had no altered electrophoretic mobility to suggest the presence of APC gene mutation in the mutation cluster region. We also examined the possible loss of heterozygosity of APC and MCC gene loci by fragment length polymorphism analysis and by polymerase chain reaction. None of the cases showed a loss of heterozygosity at the APC and MCC gene loci. The results suggested that the possibility of APC and MCC as the gene defect in the genesis of human hepatocellular carcinoma may be very rare.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10381126     DOI: 10.1016/s0304-3835(98)00238-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

2.  PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection.

Authors:  P Ryan; M W Bennett; S Aarons; G Lee; J K Collins; G C O'Sullivan; J O'Connell; F Shanahan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Authors:  S Colnot; T Decaens; M Niwa-Kawakita; C Godard; G Hamard; A Kahn; M Giovannini; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

4.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Authors:  Bin Yang; Mingzhou Guo; James G Herman; Douglas P Clark
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells.

Authors:  Lin Wang; Haiyang Li; Yujing Zhang; Regina M Santella; I Bernard Weinstein
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

6.  Detection of a Tumor Suppressor Gene Variant Predisposing to Colorectal Cancer in an 18th Century Hungarian Mummy.

Authors:  Michal Feldman; Israel Hershkovitz; Ella H Sklan; Gila Kahila Bar-Gal; Ildikó Pap; Ildikó Szikossy; Rina Rosin-Arbesfeld
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

7.  Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.

Authors:  Y Kondo; Y Kanai; M Sakamoto; T Genda; M Mizokami; R Ueda; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1999-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.